The DOI matches its Crossref record; 473 of the 473 references it cites were found in a registry or an index.
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abstract
WHAT’S NEW SINCE THE 2010 GUIDELINES? Inclusion of guidance for the diagnosis and management of cholangiocarcinoma (CCA) in patients with and without primary sclerosing cholangitis (PSC) (Figures 5, 8, and 9). Introduction of the term relevant stricture, defined as any biliary stricture of the common hepatic duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis (Table 1). In patients with equivocal MRI with cholangiopancreatography (MRI/MRCP) findings, a repeated high‐quality MRI/MRCP should be performed for diagnostic purposes. Endoscopic retrograde cholangiopancreatography (ERCP) should be avoided for the diagnosis of PSC (Figure 2). In patients with PSC without known inflammatory bowel disease (IBD), diagnostic colonoscopy with histological sampling should be performed and may be repeated every 5 years if IBD is not initially detected. Colon cancer surveillance should begin at age 15 years in patients with PSC and IBD. New clinical risk tools for PSC are available for risk stratification, but probabilities of events in individual patients should be interpreted with caution (Figure 4 and Table 3). All patients with PSC should be considered for participation in clinical trials; however, ursodeoxycholic acid (13–23 mg/kg/day) can be considered and continued if well tolerated with a meaningful improvement in alkaline phosphatase (γ‐glutamyl transferase in children) and/or symptoms with 12 months of treatment. ERCP with biliary brushings for cytology and fluorescent in situ hybridization analysis should be obtained in all patients with suspected perihilar or distal CCA. There is a new United Network for Organ Sharing policy regarding standardization of Model for End‐Stage Liver Disease exceptions for patients with PSC and recurrent cholangitis. Liver transplantation following neoadjuvant therapy is recommended for patients with perihilar CCA < 3 cm in radial diameter that is unresectable or arising in the setting of PSC and in the absence of intrahepatic or extrahepatic metastasis (Figure 9). TABLE 1 - Definitions in PSC PSC Chronic, cholestatic liver disease likely of autoimmune origin characterized by inflammation and fibrosis of intrahepatic and/or extrahepatic bile ducts, leading to the formation of bile duct strictures, and frequently associated with IBD Small‐duct PSC Less common variant of PSC that is characterized by typical cholestatic and histological features of PSC but with normal bile ducts on cholangiography PSC–AIH overlap Concurrent diagnostic features of PSC and clinical, biochemical, and histological features of AIH Secondary sclerosing cholangitis Biliary strictures due to identifiable causes that can result in secondary biliary cirrhosis IgG4 sclerosing cholangitis Biliary strictures due to elevated IgG4‐positive plasma cells in tissue and serum IgG4 elevation frequently associated with pancreatic involvement Dominant stricture A biliary stricture on ERCP with a diameter of ≤1.5 mm in the common bile duct or of ≤1 mm in the hepatic duct High‐grade stricture A biliary stricture on MRI with cholangiopancreatography with >75% reduction in the common bile duct or hepatic ducts Relevant stricture Any biliary stricture of the common bile duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis INTRODUCTION AND SCOPE OF GUIDANCE Primary sclerosing cholangitis (PSC) is a cholangiopathy characterized by chronic fibroinflammatory damage of the biliary tree and is frequently associated with inflammatory bowel disease (IBD). The majority of patients with PSC have fibrotic biliary strictures on cholangiogram, whereas a minority have small‐duct PSC, characterized by a normal cholangiogram but with histological features of PSC on liver biopsy. A small percentage have overlapping features of autoimmune hepatitis (PSC‐AIH). PSC affects both male and female individuals and can occur at any age. PSC is considered an autoimmune disease, though the pathophysiology remains poorly understood. PSC frequently results in cholestatic liver damage, cirrhosis, and liver failure and can recur in 20%–30% of patients PSC the risk of cholangiocarcinoma (CCA) and cancer is therapy for PSC, and clinical with a of diagnostic for A of new biliary strictures, is in Table for the of Liver guidance a to the diagnosis and management of PSC and CCA. are by of the of the of the and of the if of results the of and In guidance by of an and guidance on and analysis of the on the with by the at all of guidance The to a guidance on a of not available to the of a meaningful In to the of to the 2010 new for the of biliary strictures, an on for diagnosis retrograde cholangiopancreatography (ERCP) and liver of and for clinical and management of OF PSC of PSC have The majority of to have in and of and are and have that the and of PSC may be of the a PSC to the United and the United to be by PSC at to of PSC is the of and with a ag
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 473
Rafi, S., Piduru, S. M., El‐Rayes, B. F., Kauh, J. S. W., Kooby, D. A., Sarmiento, J. M., & Kim, H. S. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0463-4 · Cited by 155
Genetics of primary sclerosing cholangitis and pathophysiological implications
Jiang, X., & Karlsen, T. H. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.154 · Cited by 155
Terjung, B., Söhne, J., Lechtenberg, B., Gottwein, J. M., Muennich, M., Herzog, V., Mähler, M., Sauerbruch, T., & Spengler, U. (2009) · Gut · doi:10.1136/gut.2008.157818 · Cited by 153
Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis
Bangarulingam, S. Y., Gossard, A. A., Petersen, B. T., Ott, B. J., & Lindor, K. D. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.161 · Cited by 152
Park, S.-Y., Kim, J. H., Yoon, H.-J., Lee, I., Yoon, H., & Kim, K.-P. (2011) · Clinical Radiology · doi:10.1016/j.crad.2010.11.002 · Cited by 152
Schramm, C., Eaton, J. E., Ringe, K. I., Venkatesh, S. K., Yamamura, J., & for the MRI working group of the IPSCSG (2017) · Hepatology · doi:10.1002/hep.29293 · Cited by 152
Lamarca, Á., Barriuso, J., Chander, A., McNamara, M. G., Hubner, R. A., O'Reilly, D. A., Manoharan, P., & Valle, J. W. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.038 · Cited by 152
Al‐Chalabi, T., Portmann, B. C., Bernal, W., McFarlane, I. G., & Heneghan, M. A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03722.x · Cited by 151
Fritcher, E. G. B., Voss, J. S., Brankley, S. M., Campion, M. B., Jenkins, S. M., Keeney, M. E., Henry, M. R., Kerr, S., Chaiteerakij, R., Pestova, E. V., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.046 · Cited by 150
Murad, S. D., Kim, W. R., Therneau, T. M., Gores, G. J., Rosen, C. B. B., Martenson, J. A., Alberts, S. R., & Heimbach, J. K. (2012) · Hepatology · doi:10.1002/hep.25629 · Cited by 150
Alterations of the bile microbiome in primary sclerosing cholangitis
Liwinski, T., Zenouzi, R., John, C., Ehlken, H., Rühlemann, M. C., Bang, C., Groth, S., Lieb, W., Kantowski, M., Andersen, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318416 · Cited by 149
Jrgensen, K. K., Grzyb, K., Lundin, K. E. A., Clausen, O. P. F., Aamodt, G., Schrumpf, E., Vatn, M. H., & Boberg, K. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21699 · Cited by 149
The features of mucosa‐associated microbiota in primary sclerosing cholangitis
Torres, J., Bao, X., Goel, A., Colombel, J. ‐., Pekow, J., Jabri, B., Williams, K. M., Castillo, A., Odin, J. A., Meckel, K., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13552 · Cited by 149
Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis
Wiesner, R. H., LaRusso, N. F., Dozois, R. R., & Beaver, S. J. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90926-1 · Cited by 148
Broomé, U., Glaumann, H., Hellers, G., Nilsson, B., Sörstad, J., & Hultcrantz, R. (1994) · Gut · doi:10.1136/gut.35.1.84 · Cited by 147
Oral budesonide in the treatment of primary sclerosing cholangitis
Angulo, P., Batts, K. P., Jorgensen, R. A., LaRusso, N. A., & Lindor, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02323.x · Cited by 147
Kingham, J. G. C., Kochar, N., & Gravenor, M. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.052 · Cited by 145
Ruiz, A., Lemoinne, S., Carrat, F., Corpechot, C., Chazouillères, O., & Arrivé, L. (2014) · Hepatology · doi:10.1002/hep.26620 · Cited by 144
Self-citationVogl, T. J., Naguib, N. N. N., Nour-Eldin, N.-E. A., Bechstein, W. O., Zeuzem, S., Trojan, J., & Gruber‐Rouh, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.26407 · Cited by 144
Kawashima, H., Ito, A., Ohno, E., Itoh, Y., Ebata, T., Nagino, M., Goto, H., & Hirooka, Y. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318262b2e9 · Cited by 142
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis.
Olsson, R., Hägerstrand, I., Broomé, U., Danielsson, A., Järnerot, G., Lööf, L., Prytz, H., Ryden, B. O., & Wallerstedt, S. M. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.10.933 · Cited by 142
Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R., & Lindor, K. D. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.007 · Cited by 142
Steenstraten, I., Korkmaz, K. S., Trivedi, P. J., Inderson, A., van Hoek, B., Girondo, M. D. M. R., & Maljaars, J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15148 · Cited by 142
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
Alexander, J., Lord, J. D., Yeh, M. M., Cuevas, C. M., Bakthavatsalam, R., & Kowdley, K. V. (2008) · Liver Transplantation · doi:10.1002/lt.21394 · Cited by 141
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
de Vries, E. M., Wang, J., Williamson, K. D., Leeflang, M., Boonstra, K., Weersma, R. K., Beuers, U. H., Chapman, R. W., Geskus, R. B., & Ponsioen, C. Y. (2017) · Gut · doi:10.1136/gutjnl-2016-313681 · Cited by 141
Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis
Ali, A. H., Tabibian, J. H., Nasser‐Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J., & Lindor, K. D. (2018) · Hepatology · doi:10.1002/hep.29730 · Cited by 140
Self-citationEnhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Vesterhus, M., Hov, J. R., Holm, A., Schrumpf, E., Nygård, S., Godang, K., Andersen, I. M., Næss, S., Thorburn, D., Saffioti, F., et al. (2015) · Hepatology · doi:10.1002/hep.27825 · Cited by 138
Tedesco, D., Thapa, M., Chin, C. Y., Ge, Y., Gong, M., Li, J., Gumber, S., Speck, P., Elrod, E. J., Burd, E. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.019 · Cited by 137
Cullen, S. N., Rust, C., Fleming, K., Edwards, C., Beuers, U., & Chapman, R. W. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.023 · Cited by 136
Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study
Card, T. R., Solaymani–Dodaran, M., & West, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.017 · Cited by 136
Bone disease in patients with primary sclerosing cholangitis
Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E., & Koch, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.014 · Cited by 133
Silveira, M. G., Torok, N. J., Gossard, A. A., Keach, J. C., Jorgensen, R. A., Petz, J. L., & Lindor, K. D. (2008) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.14 · Cited by 132
Wunsch, E., Trottier, J., Milkiewicz, M., Raszeja‐Wyszomirska, J., Hirschfield, G. M., Barbier, O., & Milkiewicz, P. (2014) · Hepatology · doi:10.1002/hep.27074 · Cited by 132
Gotthardt, D. N., Runz, H., Keitel, V., Fischer, C., Flechtenmacher, C., Wirtenberger, M., Weiss, K. H., Imparato, S., Braun, A., Hemminki, K., et al. (2008) · Hepatology · doi:10.1002/hep.22485 · Cited by 130
Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis
Kummen, M., Thingholm, L. B., Rühlemann, M. C., Holm, K., Hansen, S. H., Moitinho-Silva, L., Liwinski, T., Zenouzi, R., Storm-Larsen, C., Midttun, Ø., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.058 · Cited by 129
Tanaka, A., Tazuma, S., Okazaki, K., Tsubouchi, H., Inui, K., & Takikawa, H. (2013) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.50 · Cited by 129
Colchicine treatment of primary sclerosing cholangitis
Olsson, R., Broomé, U., Danielsson, Å., Hägerstrand, I., Järnerot, G., Lööf, L., Prytz, H., Rydén, B.-O., & Wallerstedt, S. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90220-1 · Cited by 126
Borchers, A. T., Shimoda, S., Bowlus, C. L., Keen, C. L., & Gershwin, M. E. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0167-2 · Cited by 125
Self-citationCombined Vascular Resection for Locally Advanced Perihilar Cholangiocarcinoma
Mizuno, T., Ebata, T., Yokoyama, Y., Igami, T., Yamaguchi, J., Onoe, S., Watanabe, N., Kamei, Y., & Nagino, M. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004322 · Cited by 125
A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis
Hommes, D. W., Erkelens, W. G., Ponsioen, C. Y., Stokkers, P. C. F., Rauws, E. A., van der Spek, M., ten Kate, F. J. W., & van Deventer, S. J. H. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181662426 · Cited by 124
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
Iavarone, M. A., Piscaglia, F., Vavassori, S., Galassi, M., Sangiovanni, A., Venerandi, L., Forzenigo, L. V., Golfieri, R., Bolondi, L., & Colombo, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.013 · Cited by 124
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study
Strijker, M., Belkouz, A., van der Geest, L. G., van Gulik, T. M., van Hooft, J. E., de Meijer, V. E., Mohammad, N. H., de Reuver, P. R., Verheij, J., de Vos‐Geelen, J., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1590634 · Cited by 124
Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis
Carpino, G., Cardinale, V., Renzi, A., Hov, J. R., Berloco, P. B., Rossi, M., Karlsen, T. H., Alvaro, D., & Gaudio, E. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.018 · Cited by 123
Torres, J., Palmela, C., Brito, H., Bao, X., Ruiqi, H., Moura-Santos, P., da Silva, J. P., Oliveira, A. A. S., Vieira, C. L., Pérez, K., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617708953 · Cited by 122
Toy, E., Balasubramanian, S., Selmi, C. F., Li, C., & Bowlus, C. L. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-83 · Cited by 121
Self-citationPhenobarbital Effects in Cholestatic Liver Disease
BLOOMER, J. R., & BOYER, J. L. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-3-310 · Cited by 120
Dvorchik, I., Subotin, M., Demetris, J. A., Fung, J. J., Starzl, T. E., Wieand, S., & Abu-Elmagd, K. M. (2002) · Hepatology · doi:10.1053/jhep.2002.30695 · Cited by 120
Jhaveri, K. S., & Hosseini‐Nik, H. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24810 · Cited by 120
Liaskou, E., Karikoski, M., Reynolds, G. M., Lalor, P. F., Weston, C. J., Pullen, N., Salmi, M., Jalkanen, S., & Adams, D. (2010) · Hepatology · doi:10.1002/hep.24085 · Cited by 118
Cholangiocarcinoma: epidemiology and risk factors.
Bragazzi, M. C., Cardinale, V., Semeraro, R., et al. (2012) · IRIS Research product catalog (Sapienza University of Rome) · doi:10.3978/j.issn.2224-4778.2011.11.04 · Cited by 116
Gulamhusein, A. F., Eaton, J. E., Tabibian, J. H., Atkinson, E. J., Juran, B. D., & Lazaridis, K. N. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.55 · Cited by 116
Self-citationde Valle, M. B., Björnsson, E., & Lindkvist, B. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02614.x · Cited by 114
Rahimpour, S., Nasiri‐Toosi, M., Khalili, H., Daryani, N. E., Nouritaromlou, M. K., & Azizi, Z. (2016) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.254.rah · Cited by 113
Fritcher, E. G. B., Kipp, B. R., Voss, J. S., Clayton, A. C., Lindor, K. D., Halling, K. C., & Gores, G. J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.272 · Cited by 112
Ponsioen, C. Y., Arnelo, U., Bergquist, A., Rauws, E. A., Paulsen, V., Cantú, P., Parzanese, I., De Vries, E. M., van Munster, K. N., Said, K., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.034 · Cited by 112
Self-citationNutrition Support of Children With Chronic Liver Diseases
Mouzaki, M., Bronský, J., Gupte, G. L., Hojsak, I., Jahnel, J., Pai, N., Quirós‐Tejeira, R. E., Wieman, R., & Sundaram, S. S. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002443 · Cited by 112
Shah, S. C., ten Hove, J. R., Castaneda, D., Palmela, C., Mooiweer, E., Colombel, J.-F., Harpaz, N., Ullman, T. A., van Bodegraven, A. A., Jansen, J. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.023 · Cited by 109
Schramm, C., Schirmacher, P., Helmreich-Becker, I., Gerken, G., Büschenfelde, K. H. M. Z., & Lohse, A. W. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-12-199912210-00006 · Cited by 109
Goode, E. C., Clark, A., Mells, G. F., Srivastava, B., Spiess, K., Gelson, W., Trivedi, P. J., Lynch, K. D., Castren, E., Vesterhus, M. N., et al. (2018) · Hepatology · doi:10.1002/hep.30479 · Cited by 109
Rupp, C., Rössler, A., Halibasic, E., Sauer, P., Weiss, K.-H., Friedrich, K., Wannhoff, A., Stiehl, A., Stremmel, W., Trauner, M., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12979 · Cited by 108
Performance of magnetic resonance elastography in primary sclerosing cholangitis
Eaton, J. E., Dzyubak, B., Venkatesh, S. K., Smyrk, T. C., Gores, G. J., Ehman, R. L., LaRusso, N. F., Gossard, A. A., & Lazaridis, K. N. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13263 · Cited by 107
de Vries, E. M. G., de Krijger, M., Färkkilä, M. A., Arola, J. T., Schirmacher, P., Gotthardt, D. N., Goeppert, B. F., Trivedi, P. J., Hirschfield, G. M., Ytting, H., et al. (2016) · Hepatology · doi:10.1002/hep.28963 · Cited by 107
Lindström, L., Jørgensen, K. K., Boberg, K. M., Castedal, M., Rasmussen, A., Rostved, A. A., Isoniemi, H., Bottai, M., & Bergquist, A. M. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1421705 · Cited by 106
Self-citationLynch, K. D., Chapman, R. W., Keshav, S., Montano-Loza, A. J., Mason, A. L., Kremer, A. E., Vetter, M., de Krijger, M., Ponsioen, C. Y., Trivedi, P., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.05.013 · Cited by 105
Self-citationDeneau, M. R., Mack, C. L., Mogul, D. B., Perito, E. R., Valentino, P. L., Amir, A. Z., DiGuglielmo, M., Draijer, L. G., El‐Matary, W., Furuya, K. N., et al. (2020) · Hepatology · doi:10.1002/hep.31560 · Cited by 104
Self-citationInflammatory bowel disease in pregnancy
Alstead, E. M., & Nelson-Piercy, C. (2003) · Gut · doi:10.1136/gut.52.2.159 · Cited by 103
Rühlemann, M. C., Liwinski, T., Heinsen, F., Bang, C., Zenouzi, R., Kummen, M., Thingholm, L. B., Tempel, M., Lieb, W., Karlsen, T. H., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15375 · Cited by 103
Serum Lipid and Fat-Soluble Vitamin Levels in Primary Sclerosing Cholangitis
Jorgensen, R. A., Lindor, K. D., Sartin, J. S., LaRusso, N. F., & Wiesner, R. H. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199504000-00011 · Cited by 99
Pereira, P. A. B., Aho, V. T. E., Arola, J. T., Boyd, S., Jokelainen, K., Paulin, L. G., Auvinen, P., & Färkkilä, M. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182924 · Cited by 97
Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps
Wennmacker, S. Z., Lamberts, M. P., Martino, M. D., Drenth, J. P. H., Gurusamy, K. S., & van Laarhoven, C. J. H. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012233.pub2 · Cited by 97
Eaton, J. E., Thackeray, E. W., & Lindor, K. D. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.361 · Cited by 96
de Vries, E. M. G., Wang, J., Leeflang, M., Boonstra, K., Weersma, R. K., Beuers, U. H., Geskus, R. B., & Ponsioen, C. Y. (2016) · Liver International · doi:10.1111/liv.13110 · Cited by 96
Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
Self-citationWannhoff, A., Hov, J. R., Folseraas, T., Rupp, C., Friedrich, K., Anmarkrud, J. A., Weiss, K. H., Sauer, P., Schirmacher, P., Boberg, K. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.005 · Cited by 94
Kunzmann, L. K., Schoknecht, T., Poch, T., Henze, L., Stein, S., Kriz, M., Grewe, I., Preti, M., Hartl, J., Pannicke, N., et al. (2020) · Hepatology · doi:10.1002/hep.31140 · Cited by 93
Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients
Boberg, K. M., Egeland, T., & Schrumpf, E. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310005172 · Cited by 93
Boberg, K. M., Rocca, G., Egeland, T., Bergquist, A. M., Broomé, U., Caballería, L., Chapman, R. W., Hultcrantz, R. W., Mitchell, S., Parés, A. R., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.31872 · Cited by 92
Self-citationChristensen, B., Micic, D., Gibson, P. R., Yarur, A., Bellaguarda, E., Corsello, P., Gaetano, J. N., Kinnucan, J., Rao, V. L., Reddy, S., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14525 · Cited by 91
Primary sclerosing cholangitis: a modified classification of cholangiographic findings.
Majoie, C. B. L. M., Reeders, J. W. A. J., Sanders, J., Huibregtse, K., & Jansen, P. L. M. (1991) · American Journal of Roentgenology · doi:10.2214/ajr.157.3.1651643 · Cited by 91
Long-Term Outcome of Liver Transplantation in Patients With PSC: A Comparative Analysis With PBC
Maheshwari, A., Yoo, H. Y., & Thuluvath, P. J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04050.x · Cited by 91
Incidence Rates of Intra- and Extrahepatic Cholangiocarcinomas in Denmark From 1978 Through 2002
Jepsen, P., Vilstrup, H., Tarone, R. E., Friis, S., & Sørensen, H. T. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk201 · Cited by 91
Kevans, D., Tyler, A. D., Holm, K., Jørgensen, K. K., Vatn, M. H., Karlsen, T. H., Kaplan, G. G., Eksteen, B., Gevers, D., Hov, J. R., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv204 · Cited by 91
Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A., Harrison, M. E., McCashland, T. M., Befeler, A. S., Harnois, D. M., Jorgensen, R. A., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04863.x · Cited by 89
Venkatesh, S. K., Welle, C. L., Miller, F. H., Jhaveri, K. S., Ringe, K. I., Eaton, J. E., Bungay, H. K., Arrivé, L., Ba‐Ssalamah, A., Grigoriadis, A., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08147-7 · Cited by 88
Self-citationLow risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis
Zenouzi, R., Weismüller, T. J., Hübener, P., Schulze, K., Bubenheim, M., Pannicke, N., Weiler–Normann, C., Lenzen, H., Manns, M. P., Lohse, A. W., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.008 · Cited by 86
Gordon, F. D., Goldberg, D. S., Goodrich, N. P., et al. (2016) · Liver Transplantation · doi:10.1002/lt.24496 · Cited by 86
Sørensen, J. Ø., Nielsen, O. H., Andersson, M., Ainsworth, M. A., Ytting, H., Bélard, E., & Jess, T. (2017) · Liver International · doi:10.1111/liv.13548 · Cited by 86
A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis
Bharucha, A. E., Jorgensen, R. A., Lichtman, S. N., LaRusso, N. F., & Lindor, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02324.x · Cited by 86
Alvaro, D., Bragazzi, M. C., Benedetti, A., Fabris, L., Fava, G., Invernizzi, P., Marzioni, M., Nuzzo, G., Strazzabosco, M., & Stroffolini, T. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.05.002 · Cited by 85
Krugliak Cleveland, N., Rubin, D. T., Hart, J., Weber, C. R., Meckel, K., Tran, A. L., Aelvoet, A. S., Pan, I., Gonsalves, A., Gaetano, J. N., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.07.023 · Cited by 85
Jørgensen, K. K., Lindström, L., Cvancarova, M., Karlsen, T. H., Castedal, M., Friman, S., Schrumpf, E., Foss, A. E., Isoniemi, H., Nordin, A. J., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.027 · Cited by 84
Self-citationGeoepidemiology of primary sclerosing cholangitis: A critical review
Tanaka, A., & Takikawa, H. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.07.005 · Cited by 84
Pathogenesis and Management of Pruritus in PBC and PSC
Kremer, A. E., Namer, B., Bolier, R., Fischer, M. J. M., Elferink, R. P. J. O., & Beuers, U. H. (2015) · Digestive Diseases · doi:10.1159/000440829 · Cited by 84
Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency
Parra‐Robert, M., Molina, V., CANIS, S. M., Filella, X., Fradera, J., & PORTO, R. M. (2018) · Anticancer Research · doi:10.21873/anticanres.12931 · Cited by 84
de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International · doi:10.1111/liv.13402 · Cited by 83
Pediatric liver transplantation for primary sclerosing cholangitis
Miloh, T., Anand, R., Yin, W., Vos, M. B., Kerkar, N. N., & Alonso, E. M. (2011) · Liver Transplantation · doi:10.1002/lt.22320 · Cited by 83
A Pilot Study of Etanercept in the Treatment of Primary Sclerosing Cholangitis
Epstein, M. P., & Kaplan, M. M. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000011827.87103.2e · Cited by 83
Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis
Tabibian, J. H., Gossard, A. A., El‐Youssef, M., Eaton, J. E., Petz, J., Jorgensen, R. A., Enders, F. B., Tabibian, A., & Lindor, K. D. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000102 · Cited by 82
Self-citationPrimary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
O’Toole, A., Alakkari, A., Keegan, D., Doherty, G. A., Mulcahy, H. E., & O’Donoghue, D. P. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.11.010 · Cited by 82
van Hoogstraten, H. J. F., Wolfhagen, F. H. J., van de Meeberg, P. C., Kuiper, H., Nix, G. A. J. J., Becx, M. C., Hoek, A. C., van Houte, D. P. F., Rijk, M. C. M., Salemans, J. M. J. I., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80059-7 · Cited by 81
Interactions Between Chronic Liver Disease and Inflammatory Bowel Disease
Loftus, E. V., Sandborn, W. J., Lindor, K. D., & LaRusso, N. F. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030408 · Cited by 81
Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis
Rühlemann, M. C., Heinsen, F., Zenouzi, R., Lieb, W., Franke, A., & Schramm, C. (2016) · Gut · doi:10.1136/gutjnl-2016-312180 · Cited by 81
Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up
Khoshpouri, P., Habibabadi, R. R., Hazhirkarzar, B., Ameli, S., Ghadimi, M., Ghasabeh, M. A., Menias, C. O., Kim, A., Li, Z., & Kamel, I. R. (2019) · Radiographics · doi:10.1148/rg.2019180213 · Cited by 81
PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)
Stinton, L. M., Bentow, C., Mähler, M., Norman, G. L., Eksteen, B., Mason, A. L., Kaplan, G. G., Lindkvist, B., Hirschfield, G. M., Milkiewicz, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112877 · Cited by 80
Barner-Rasmussen, N., Pukkala, E., Jussila, A., & Färkkilä, M. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1707277 · Cited by 80
Nationwide treatment and outcomes of perihilar cholangiocarcinoma
van Keulen, A., Franssen, S., van der Geest, L. G., de Boer, M. T., Coenraad, M. J., van Driel, L. M. J. W., Erdmann, J. I., Mohammad, N. H., Heij, L. R., Klümpen, H., et al. (2021) · Liver International · doi:10.1111/liv.14856 · Cited by 80
Olsson, R., Glaumann, H., Almer, S., Broomé, U., Lebrun, B., Bergquist, A., Björnsson, E., Prytz, H., Danielsson, Å., & Lindgren, S. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.06.004 · Cited by 79
Self-citationSingh, S., Varayil, J. E., Loftus, E. V., & Talwalkar, J. A. (2013) · Liver Transplantation · doi:10.1002/lt.23741 · Cited by 79
Kim, S., Lee, C. H., Kim, B. H., Kim, W. B., Yeom, S. K., Kim, K. A., & Park, C. M. (2012) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e3182706562 · Cited by 79
Bowlus, C. L., Li, C., Karlsen, T. H., Lie, B. A., & Selmi, C. F. (2010) · Liver Transplantation · doi:10.1002/lt.22161 · Cited by 79
Self-citationTrends in the incidence and management of biliary tract cancer: A French population-based study
Lepage, C., Cottet, V., Chauvenet, M., Phelip, J., Bedenne, L., Faivre, J., & Bouvier, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.039 · Cited by 79
Moctezuma-Velazquez, C., Saffioti, F., Tasayco-Huaman, S., Casu, S., Mason, A., Roccarina, D., Vargas, V., Nilsson, J.-E., Tsochatzis, E., Augustin, S., et al. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0265-7 · Cited by 78
Fritcher, E. G. B., Voss, J. S., Jenkins, S. M., Lingineni, R. K., Clayton, A. C., Roberts, L. R., Halling, K. C., Talwalkar, J. A., Gores, G. J., & Kipp, B. R. (2013) · Cancer Cytopathology · doi:10.1002/cncy.21331 · Cited by 78
Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom
Liang, H., Manne, S., Shick, J., Lissoos, T. W., & Dolin, P. (2017) · Medicine · doi:10.1097/md.0000000000007116 · Cited by 78
Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
Ponsioen, C. Y., Lindor, K. D., Mehta, R., & Dimick‐Santos, L. (2018) · Hepatology · doi:10.1002/hep.29882 · Cited by 78
Lemoinne, S., Cazzagon, N., El Mouhadi, S., Trivedi, P. J., Dohan, A., Kemgang, A., Ben Belkacem, K., Housset, C., Chretien, Y., Corpechot, C., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.03.013 · Cited by 78
Self-citationOh, D., Lee, K.-H., Lee, D., Kim, T. Y., Bang, J., Nam, A., Lee, Y., Zhang, Q., Rebelatto, M. C., Li, W., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.4520 · Cited by 78
Welsh, F. K. S., & Wigmore, S. J. (2004) · Transplantation · doi:10.1097/01.tp.0000113807.74942.d2 · Cited by 77
Pregnancy in primary sclerosing cholangitis
Wellge, B. E., Sterneck, M., Teufel, A., Rust, C., Franke, A., Schreiber, S., Berg, T., Günther, R., Kreisel, W., zu Eulenburg, C., et al. (2011) · Gut · doi:10.1136/gut.2010.228924 · Cited by 76
Tse, C. S., Loftus, E. V., Raffals, L. E., Gossard, A. A., & Lightner, A. L. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14829 · Cited by 76
Tacrolimus for the treatment of primary sclerosing cholangitis
Talwalkar, J. A., Gossard, A. A., Keach, J. C., Jorgensen, R. A., Petz, J. L., & Lindor, R. N. K. D. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01441.x · Cited by 76
Dhillon, A. K., Kummen, M., Trøseid, M., Åkra, S., Liaskou, E., Moum, B. A., Vesterhus, M. N., Karlsen, T. H., Seljeflot, I., & Hov, J. R. (2018) · Liver International · doi:10.1111/liv.13979 · Cited by 75
Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis
Freedman, B. L., Danford, C. J., Patwardhan, V. R., & Bonder, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051449 · Cited by 75
Ali, A. H., Damman, J., Shah, S. B., Davies, Y. K., Hurwitz, M., Stephen, M., Lemos, L. M., Carey, E. J., Lindor, K. D., Buness, C. W., et al. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1787501 · Cited by 75
The evolution of natural history of primary sclerosing cholangitis
Takakura, W., Tabibian, J. H., & Bowlus, C. L. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000333 · Cited by 74
Self-citationLemoinne, S., Pares, A., Reig, A., Ben Belkacem, K., Kemgang Fankem, A. D., Gaouar, F., Poupon, R., Housset, C., Corpechot, C., & Chazouillères, O. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.06.009 · Cited by 74
Immunohistochemical analysis of inflammation in primary sclerosing cholangitis
Ponsioen, C. Y., Kuiper, H., ten Kate, F. J. W., de Wit, M. V. M., van Deventer, S. J. H., & Tytgat, G. N. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199907000-00015 · Cited by 73
Fraga, M. C., Fournier, N., Safroneeva, E., Pittet, V. E. H., Godat, S., Straumann, A., Nydegger, A., Vavricka, S. R., Moradpour, D., & Schoepfer, A. M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000747 · Cited by 73
Oral Nicotine in Treatment of Primary Sclerosing Cholangitis (A Pilot Study)
Angulo, P., Bharucha, A. E., Jorgensen, R. A., DeSotel, C. K., Sandborn, W. J., LaRusso, N. F., & Lindor, K. D. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026673811278 · Cited by 72
Validation of a cholangiographic prognostic model in primary sclerosing cholangitis
Ponsioen, C. Y., Reitsma, J. B., Boberg, K. M., Aabakken, L., Rauws, E. A., & Schrumpf, E. (2010) · Endoscopy · doi:10.1055/s-0030-1255527 · Cited by 72
ERCP-related adverse events in patients with primary sclerosing cholangitis
Navaneethan, U., Jegadeesan, R., Nayak, S., Lourdusamy, V., Sanaka, M. R., Vargo, J. J., & Parsi, M. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.06.030 · Cited by 72
Rudolph, G., Gotthardt, D. N., Kloeters-Plachky, P., Rost, D., Kulaksiz, H., & Stiehl, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.030 · Cited by 72
Ehlken, H., Wroblewski, R., Corpechot, C., Arrivé, L., Rieger, T., Hartl, J., Lezius, S., Huebener, P., Schulze, K., Zenouzi, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164224 · Cited by 70
Self-citationLowery, M. A., Goff, L. W., Keenan, B. P., Jordan, E., Wang, R., Bocobo, A. G., Chou, J. F., O'Reilly, E. M., Harding, J. J., Kemeny, N. E., et al. (2019) · Cancer · doi:10.1002/cncr.32463 · Cited by 70
Risk factors for complications of ERCP in primary sclerosing cholangitis
Ismail, S., Kylänpää, L., Mustonen, H. K., Halttunen, J., Lindström, O. K., Jokelainen, K., Udd, M., & Färkkilä, M. A. (2012) · Endoscopy · doi:10.1055/s-0032-1325677 · Cited by 69
Cheung, A. C., Patel, H., Meza-Cardona, J., Cino, M., Sockalingam, S., & Hirschfield, G. M. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4013-1 · Cited by 68
Goyal, L., Meric‐Bernstam, F., Hollebecque, A., Valle, J. W., Morizane, C., Karasic, T. B., Abrams, T. A., Furuse, J., He, Y., Soni, N., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.108 · Cited by 68
Biliary Multifocal Chromosomal Polysomy and Cholangiocarcinoma in Primary Sclerosing Cholangitis
Eaton, J. E., Fritcher, E. G. B., Gores, G. J., Atkinson, E. J., Tabibian, J. H., Topazian, M. D., Gossard, A. A., Halling, K. C., Kipp, B. R., & Lazaridis, K. N. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.433 · Cited by 67
Self-citationEaton, J. E., Juran, B. D., Atkinson, E. J., Schlicht, E. M., Xie, X., de Andrade, M., Lammert, C. S., Luketic, V. A., Odin, J. A., Koteish, A. A., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13154 · Cited by 67
Primary sclerosing cholangitis associated with inflammatory bowel disease: an update
Rossi, R. E., Conte, D., & Massironi, S. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000532 · Cited by 67
Factors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis
Valle, M., Rahman, M., Lindkvist, B., Bjornsson, E. S., Chapman, R. W., & Kalaitzakis, E. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.025 · Cited by 66
Bandyopadhyay, D., Bandyopadhyay, S. K., Ghosh, P., De, A., Bhattacharya, A., Dhali, G. K., & Das, K. (2015) · Indian Journal of Gastroenterology · doi:10.1007/s12664-015-0598-8 · Cited by 66
Iwasawa, K., Suda, W., Tsunoda, T., Oikawa‐Kawamoto, M., Umetsu, S., Inui, A., Fujisawa, T., Morita, H., Sogo, T., & Hattori, M. (2016) · Gut · doi:10.1136/gutjnl-2016-312533 · Cited by 66
Jørgensen, K. K., Lindström, L., Cvancarova, M., Castedal, M., Friman, S., Schrumpf, E., Foss, A., Isoniemi, H., Nordin, A., Holte, K., et al. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.685754 · Cited by 65
Self-citationDecock, S., Roelandts, R., Steenbergen, W. V., Laleman, W., Cassiman, D., Verslype, C., Fevery, J., Pelt, J. V., & Nevens, F. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.023 · Cited by 64
Osman, K. T., Maselli, D. B., Idilman, I. S., Rowan, D. J., Viehman, J. K., Harmsen, W. S., Harnois, D. M., Carey, E. J., Gossard, A. A., LaRusso, N. F., et al. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001433 · Cited by 64
Ludvigsson, J. F., Bergquist, A., Ajne, G., Kane, S., Ekbom, A., & Stephansson, O. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.011 · Cited by 63
Self-citationPregnancy in patients with primary sclerosing cholangitis
Janczewska, I., Olsson, R., Hultcrantz, R., & Broome, U. (1996) · Liver · doi:10.1111/j.1600-0676.1996.tb00754.x · Cited by 63
Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis
Mizuno, S., Hirano, K., Isayama, H., Watanabe, T., Yamamoto, N., Nakai, Y., Sasahira, N., Tada, M., Omata, M., & Koike, K. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.281 · Cited by 63
Statin use is associated with improved outcomes of patients with primary sclerosing cholangitis
Stokkeland, K., Höijer, J., Bottai, M., Söderberg-Löfdal, K., & Bergquist, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.11.002 · Cited by 63
Self-citationAmerican Gastroenterological Association (AGA) on Osteoporosis and Hepatic Disorders (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01060-6 · Cited by 63
Sutton, M. E., Bense, R. D., Lisman, T., van der Jagt, E. J., van den Berg, A. P., & Porte, R. J. (2014) · Liver Transplantation · doi:10.1002/lt.23827 · Cited by 62
Landi, A., Weismüller, T. J., Lankisch, T. O., Santer, D. M., Tyrrell, D. L., Manns, M. P., & Houghton, M. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0075 · Cited by 62
Pandanaboyana, S., Bell, R., Bartlett, A. J., McCall, J., & Hidalgo, E. (2015) · Transplant International · doi:10.1111/tri.12513 · Cited by 61
Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis
Srivastava, B., Mells, G. F., Cordell, H. J., Muriithi, A. W., Brown, M., Ellinghaus, E., Franke, A., UK-PSC Consortium, Karlsen, T. H., Sandford, R. N., et al. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.682090 · Cited by 61
Liver Transplant for Cholangiocarcinoma
Zamora‐Valdés, D., & Heimbach, J. K. (2018) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2018.01.002 · Cited by 60
Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis
Goldberg, D. S., Camp, A., Martinez-Camacho, A., Forman, L., Fortune, B., & Reddy, R. K. (2013) · Liver Transplantation · doi:10.1002/lt.23587 · Cited by 58
Self-citationLepistö, A., Kärkkäinen, P., & Järvinen, H. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20384 · Cited by 58
Pirfenidone in the Treatment of Primary Sclerosing Cholangitis
Angulo, P., MacCarty, R. L., Sylvestre, P. B., Jorgensen, R. A., Wiesner, R. H., LaRusso, N. A., & Lindor, K. D. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1013240225965 · Cited by 57
Wu, C.-W., Eiserich, J. P., Ansari, A. A., Coppel, R. L., Balasubramanian, S., Bowlus, C. L., Gershwin, E. M., & Water, J. V. D. (2003) · Hepatology · doi:10.1053/jhep.2003.50407 · Cited by 57
Self-citationGhonem, N. S., Auclair, A. M., Hemme, C. L., Gallucci, G. M., de la Rosa Rodriguez, R., Boyer, J. L., & Assis, D. N. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1930 · Cited by 57
Self-citationEaton, J. E., Sen, A., Hoodeshenas, S., Schleck, C. D., Harmsen, W. S., Gores, G. J., LaRusso, N. F., Gossard, A. A., Lazaridis, K. N., & Venkatesh, S. K. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.10.041 · Cited by 56
Eaton, J. E., Welle, C. L., Bakhshi, Z., Sheedy, S. P., Idilman, I. S., Gores, G. J., Rosen, C. B., Heimbach, J. K., Taner, T., Harnois, D. M., et al. (2021) · Hepatology · doi:10.1002/hep.31575 · Cited by 56
Ruppert, K. M., Kuo, S., DiMartini, A. F., & Balan, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.043 · Cited by 56
Gwela, A., Siddhanathi, P., Chapman, R. W., Travis, S. P. L., Powrie, F. M., Arancibia-Cárcamo, C. V., & Geremia, A. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx050 · Cited by 56
Bessissow, T., Dulai, P. S., Restellini, S., Landry, T., Bisschops, R., Murad, M. H., & Singh, S. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy188 · Cited by 56
Trivedi, P. J., Muir, A. J., Levy, C., Bowlus, C. L., Manns, M. P., Lu, X., Crans, G., Chung, C., Subramanian, G. M., Myers, R. P., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.07.032 · Cited by 55
Self-citationPathogenesis and management of pruritus in cholestatic liver disease
Imam, M. H., Gossard, A. A., Sinakos, E., & Lindor, K. D. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07109.x · Cited by 55
Bezafibrate for the treatment of primary sclerosing cholangitis
Mizuno, S., Hirano, K., Tada, M., Yamamoto, K., Yashima, Y., Yagioka, H., Kawakubo, K., Ito, Y., Kogure, H., Sasaki, T., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0204-x · Cited by 54
Sterling, R. K., Salvatori, J., Luketic, V. A., Sanyal, A. J., Fulcher, A. S., Stravitz, R. T., Contos, M. J., Mills, A. S., & Shiffman, M. L. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02214.x · Cited by 54
Guerra, I., Bujanda, L., Castro, J., Merino, O., Tosca-Cuquerella, J., Camps, B., Gutiérrez, A., Gordillo, J., de Castro, L., Iborra, M., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz094 · Cited by 54
Kim, Y., Spolverato, G., Amini, N., Margonis, G. A., Gupta, R., Ejaz, A. M., & Pawlik, T. M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4419-1 · Cited by 53
Sclerosing Cholangitis in Children and Adolescents
Mieli‐Vergani, G., & Vergani, D. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.008 · Cited by 53
Hilscher, M. B., Enders, F. B., Carey, E. J., Lindor, K. D., & Tabibian, J. H. (2016) · PubMed · doi:10.5604/16652681.1193721 · Cited by 53
Self-citationDeneau, M. R., Mack, C. L., Abdou, R., Amin, M. D., Amir, A. Z., Auth, M. K. H., Bazerbachi, F., Broderick, A. M., Chan, A. C. Y., DiGuglielmo, M., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1251 · Cited by 53
Self-citationEffects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis
Hedin, C. R. H., Sado, G., Ndegwa, N., Lytvyak, E., Mason, A., Montano-Loza, A., Gerussi, A., Saffioti, F., Thorburn, D., Nilsson, E., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.014 · Cited by 52
Self-citationvon Seth, E., Arnelo, U., Enochsson, L., & Bergquist, A. M. (2014) · Liver International · doi:10.1111/liv.12640 · Cited by 52
Self-citationLo, S. K., Fleming, K. A., & Chapman, R. W. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80604-x · Cited by 50
Barrie, A. M., Mourabet, M. E., Weyant, K. A., Clarke, K., Gajendran, M., Rivers, C. R., Park, S. Y., Hartman, D. J., Saul, M. I., Regueiro, M. D., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2329-7 · Cited by 50
Venkatesh, P. G. K., Jegadeesan, R., Gutierrez, N. G., Sanaka, M. R., & Navaneethan, U. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.02.002 · Cited by 50
Classifications and misclassification in cholangiocarcinoma
Cardinale, V. (2019) · Liver International · doi:10.1111/liv.13998 · Cited by 50
Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis
Lapidot, Y., Amir, A., Ben-Simon, S., Veitsman, E., Cohen‐Ezra, O., Davidov, Y., Weiss, P., Bradichevski, T., Segev, S., Koren, O., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10089-z · Cited by 50
Recurrent and De Novo Autoimmune Liver Diseases
Mendes, F. D., Couto, C. A., & Levy, C. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.08.008 · Cited by 49
Zenouzi, R., Liwinski, T., Yamamura, J., Weiler‐Normann, C., Sebode, M., Keller, S. H., Lohse, A. W., Schramm, C., & the International PSC Study Group (IPSCSG) (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14797 · Cited by 49
Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells
Gupta, V., Gupta, I., Park, J., Bram, Y., & Schwartz, R. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.075 · Cited by 49
Younossi, Z. M., Afendy, A., Stepanova, M., Racila, A., Nader, F., Gomel, R., Safer, R., Lenderking, W. R., Skalicky, A., Kleinman, L., et al. (2018) · Hepatology · doi:10.1002/hep.29664 · Cited by 48
Self-citationTornai, T., Pályu, E., Vitális, Z., Tornai, I., Tornai, D., Antal‐Szalmás, P., Norman, G. L., Shums, Z., Veres, G., Dezsőfi, A., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5412 · Cited by 48
Ricciuto, A., Fish, J., Carman, N., Walters, T. D., Church, P. C., Hansen, B. E., Crowley, E., Siddiqui, I., Nguyen, G. C., Kamath, B. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.020 · Cited by 47
Autoantibodies and Liver Disease: Uses and Abuses
Zeman, M. V., & Hirschfield, G. M. (2010) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2010/431913 · Cited by 47
Kuo, A., Gomel, R., Safer, R., Lindor, K. D., Everson, G. T., & Bowlus, C. L. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.047 · Cited by 47
Self-citationCoufal, Š., Galanová, N., Bajer, L., Gajdárová, Z., Schierová, D., Zakostelska, Z. J., Kostovcikova, K., Jackova, Z., Stehlíková, Z., Drastich, P., et al. (2019) · Cells · doi:10.3390/cells8070719 · Cited by 47
Cazzagon, N., Lemoinne, S., Mouhadi, S. E., Trivedi, P. J., Gaouar, F., Kemgang, A., Belkacem, K. B., Floreani, A., Hirschfield, G. M., Chrétien, Y., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000461 · Cited by 47
Self-citationThe Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
Deneau, M. R., Mack, C. L., Perito, E. R., Ricciuto, A., Valentino, P. L., Amin, M. D., Amir, A. Z., Aumar, M., Auth, M. K. H., Broderick, A., et al. (2020) · Hepatology · doi:10.1002/hep.31393 · Cited by 47
Self-citationManagement of primary sclerosing cholangitis and its complications: an algorithmic approach
Prokopič, M., & Beuers, U. H. (2020) · Hepatology International · doi:10.1007/s12072-020-10118-x · Cited by 47
van Erp, L. W., Cunningham, M., Narasimman, M., Ale Ali, H., Jhaveri, K., Drenth, J. P. H., Janssen, H. L. A., Levy, C., Hirschfield, G. M., Hansen, B. E., et al. (2020) · Liver International · doi:10.1111/liv.14326 · Cited by 46
Bakhshi, Z., Hilscher, M. B., Gores, G. J., Harmsen, W. S., Viehman, J. K., LaRusso, N. F., Gossard, A. A., Lazaridis, K. N., Lindor, K. D., & Eaton, J. E. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01663-1 · Cited by 46
Cauldwell, M., Mackie, F., Steer, P., Henehghan, M., Baalman, J., Brennand, J., Johnston, T., Dockree, S., Hedley, C., Jarvis, S., et al. (2020) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16119 · Cited by 46
Åberg, F. O., Höckerstedt, K., Roine, R. P., Sintonen, H., & Isoniemi, H. (2012) · Clinical Transplantation · doi:10.1111/j.1399-0012.2012.01597.x · Cited by 45
Heikius, B., Niemelä, S., Lehtola, J., Karttunen, T. J., & Lahde, S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709000186 · Cited by 45
Ricciuto, A., Hansen, B. E., Ngo, B., Aloi, M., Walters, T. D., Church, P. C., Mazurek, A., Khan, M. A., Carman, N., Siddiqui, I. F. S., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.048 · Cited by 45
Cited by
Sex differences in chronic liver disease and benign liver lesions
Cooper, K. M., Delk, M., Devuni, D., & Sarkar, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100870 · Cited by 38
Immunobiology of primary sclerosing cholangitis
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025) · Hepatology · doi:10.1097/hep.0000000000001080 · Cited by 20
Self-citation
Metadata
- Authors
- Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., Tabibian, J. H., & Assis, D. N.
- Venue
- Hepatology
- Published
- 2022-10-20
- Volume
- 77
- Issue
- 2
- Pages
- 659-702
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4295048810
- Cited by
- 428
- References
- 473
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.